Standard BioTools
LAB
142 hedge funds and large institutions have $487M invested in Standard BioTools in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 21 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 40
5% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 21
1% more funds holding
Funds holding: 141 → 142 (+1)
0.99% less ownership
Funds ownership: 75.76% → 74.78% (-0.99%)
10% less capital invested
Capital invested by funds: $543M → $487M (-$55.5M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
93% less call options, than puts
Call options by funds: $12K | Put options by funds: $178K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
+$5.83M |
| 2 |
BlackRock
New York
|
+$4.48M |
| 3 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
+$3.97M |
| 4 |
Morgan Stanley
New York
|
+$2.99M |
| 5 |
RA
Royce & Associates
New York
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$10.5M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$5.51M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$5.5M |
| 4 |
Primecap Management
Pasadena,
California
|
-$4.32M |
| 5 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$562K |
LAB Hedge Fund Activity: Q4 2024 in Review
142 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2024, worth a combined $487M — down 10% from $543M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new LAB positions and 21 closed out — a net gain of 1 holder — while 45 added to existing stakes and 40 trimmed.
The largest buyer was Mirabella Financial Services, opening a new position worth an estimated $5.83M. The largest seller was ARK Investment Management, cutting an estimated $10.5M.
- 142 institutional investors held Standard BioTools (LAB) as of Q4 2024, up from 141 in Q3 2024.
- Funds reported $487M of Standard BioTools stock for Q4 2024, down 10% quarter-over-quarter.
- 22 funds opened new Standard BioTools positions in Q4 2024 and 21 closed out, a net change of +1 holder.
- The largest Standard BioTools buyer in Q4 2024 was Mirabella Financial Services, an estimated $5.83M added.
- The largest Standard BioTools seller in Q4 2024 was ARK Investment Management, an estimated $10.5M sold.
Based on aggregated 13F filings for Q4 2024.